Cisatracurium – A “safe” neuromuscular blocking agent? [PDF]
Anesthetic agents are an important cause of drug anaphylaxis, with neuromuscular blocking agents (NMBA) being a common cause of intraoperative anaphylaxis.
Gonçalves, Tânia +10 more
core +1 more source
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis
Background Primary focal hyperhidrosis (PFH) is an autonomic neurological disease in which exocrine glands are oversecreted due to autonomic dysfunction of the sympathetic nervous system. Chrna1 promotes the pathogenesis of PFH.
Jian‐Bo Lin +3 more
doaj +1 more source
Background: Stability study of a 10 mg/mL injectable cisatracurium solution stored refrigerated in amber glass ampoules for 18 months (M18). Methods: 4000 ampoules were aseptically compounded using European Pharmacopoeia (EP)-grade cisatracurium besylate,
Marine Roche +7 more
doaj +1 more source
Anaphylactic reactions after cisatracurium administration in two patients -a report of two cases- [PDF]
Cisatracurium was initially characterized to have no evident histamine-releasing potential with excellent cardiovascular stability. However, severe anaphylactic reactions to cisatracurium that resulted in bronchospasms and cardiovascular collapse have ...
Yangin Yoon +5 more
doaj +1 more source
The effect of low dose ketamine and priming of cisatracurium on the intubating condition and onset time of cisatracurium [PDF]
BackgroundBoth ketamine and priming may accelerate the onset time of neuromuscular blocking agents. We investigate the effect of low dose ketamine and cisatracurium priming on the intubating condition and onset time of cisatracurium.MethodsAfter ...
Byung-Ryang Ahn +4 more
doaj +1 more source
Effects and safety of continuous infusion of cisatracurium in laparoscopic abdominal surgery [PDF]
Objective To explore the effects and safety of continuous infusion of cisatracurium in laparoscopic abdominal surgery. Methods Ninety patients undergoing elective laparoscopic abdominal surgery in Gubei Branch of Ruijin Hospital from January 2019 to ...
ZHU Qianlin, LI Kai, ZI Yuqiang, JIN Weifang
doaj +1 more source
Background Previous studies reported a slow neuromuscular response with the currently recommended dose of cisatracurium in critically ill patients. Pharmacokinetic and pharmacodynamic studies of cisatracurium in critically ill patients are still limited.
Panadda Panusitthikorn +4 more
doaj +1 more source
Efficacy and Safety of Cisatracurium in Electroconvulsive Therapy: A Randomized, Single-blind, Clinical Trial [PDF]
Background: Electroconvulsive therapy (ECT) is widely accepted as a safe and effective treatment in psychiatric patients. Although succinylcholine is the choice of muscle relaxant in this process, its adverse effects and contraindications must be ...
Siamak Rimaz +7 more
doaj +1 more source
A comparison of the clinical duration and recovery characteristics of cisatracurium after priming using rocuronium or cisatracurium: preliminary study [PDF]
BackgroundThe priming technique can speed up the onset of cisatracurium during intubation. However, there have been no reports on the effect of the priming technique on duration or recovery profile of cisatracurium.
Ki Tae Jung +3 more
doaj +1 more source
Comparison of the Onset of Action, Maintenance, and Recovery of Three Weight-based Dosing of Cisatracurium in Patients with Morbid Obesity in Laparoscopic Bariatric Surgery: A Randomized Clinical Trial [PDF]
Background: For patients with morbid obesity, different cisatracurium dosage regimens are recommended. This study aimed to compare the onset of action, the sufficiency of neuromuscular blockade during infusion, and the recovery of the three distinct ...
Faranak Rokhtabnak +4 more
doaj +1 more source

